Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases
Abstract
Atrial natriuretic peptide (ANP), a peptide released from the cardiac atria, compensates blood volume expansion by its diuretic, natriuretic and vasoactive properties. We measured human plasma ANP(hANP) levels in patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and progressive systemic sclerosis (PSS) and found that their values were higher than those of healthy controls. In SLE patients, hANP levels correlated with serum creatinine concentration and the patients with proteinuria showed high levels of hANP. Administration of large amount of corticosteroid as a remission induction of the patients with SLE caused high levels of hANP. In patients with PSS, %FEV1 showed strong inverse correlations between hANP levels, and the patients with an enlarged second curvature of the heart had high levels of hANP. In patients with RA, no significant correlation was found between hANP levels and clinical variables including patients' age.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In chronic inflammatory diseases, serum levels of atrial natriuretic factor and NT-brain natriuretic factor are markedly increased, indicating volume overload.
“there are obvious signs of volume overload in chronic inflammatory diseases because serum levels of atrial natriuretic factor and NT-brain natriuretic factor are markedly increased in different diseases [49–52].”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [49]
NT-brain natriuretic factor decreases with TNF neutralization therapy but increases under therapy with volume retention-inducing glucocorticoids.
“NT-brain natriuretic factor decreased with TNF neutralization therapy but increased under therapy with volume retention—inducing glucocorticoids [49, 51].”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [49]
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · see citing works
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,925 · see citing works
de Bold, A. J., Borenstein, H., Veress, A. T., & Sonnenberg, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90370-2 · Cited by 3,144 · see citing works
revision of diagnostic criteria for rheumatoid arthritis
Ropes, M. W., Bennett, G. A., COBB, S., Jacox, R. F., & Jessar, R. A. (2001) · CRC Press eBooks · doi:10.3109/9780203214237-47 · Cited by 2,237 · see citing works
Atrial natriuretic factor—a circulating hormone stimulated by volume loading
Lang, R. E., Thölken, H., Ganten, D., Luft, F. C., Ruskoaho, H. J., & Unger, T. (1985) · Nature · doi:10.1038/314264a0 · Cited by 1,229 · see citing works
Radioautographic localization of125I-atrial natriuretic fator (ANF) in rat tissues
Bianchi, C. F., Gutkowska, J., Thibault, G., et al. (1985) · Histochemistry and Cell Biology · doi:10.1007/bf02450479 · Cited by 289 · see citing works
Atrial natriuretic peptide mRNA is regulated by glucocorticoids invivo
Gardner, D. G., Hane, S., Trachewsky, D., et al. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80283-2 · Cited by 119 · see citing works
A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine
Marumo, F., Sakamoto, H., Andò, K., et al. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)91200-3 · Cited by 95 · see citing works
Bronchodilator effect of atrial natriuretic peptide in asthma.
Hulks, G., Jardine, A. G., Connell, J. M. C., et al. (1989) · BMJ · doi:10.1136/bmj.299.6707.1081 · Cited by 59 · see citing works
Anderson, J. V., Raine, A. E. G., Proudler, A. J., et al. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1100193 · Cited by 55 · see citing works
Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide.
Gardner, D. G., & Schultz, H. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114714 · Cited by 52 · see citing works
Plasma concentrations of atrial natriuretic peptide in various diseases.
Nozuki, M., Mouri, T., Itoi, K., et al. (1986) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.148.439 · Cited by 38 · see citing works
Adnot, S., Andrivet, P., Chabrier, P. E., et al. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.5_pt_1.1178 · Cited by 23 · see citing works
Release of atrial natriuretic factor (ANF) induced by acute airway obstruction
Amyot, R., Michoud, M.-C., Leduc, T., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92505-9 · Cited by 11 · see citing works
Gordon, R. D., Tunny, T. J., Klemm, S. A., et al. (1986) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology
Straub, R. H. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0861-8 · Cited by 105 · see citing works
- Authors
- Yasuda, M., Yasuda, D., Tomooka, K., & Nobunaga, M.
- Affiliations
- Kyushu University (JP)
- Venue
- Clinical Rheumatology
- Published
- 1993-06
- Volume
- 12
- Issue
- 2
- Pages
- 231-235
- ISSN
- 0770-3198 (ISSN-L)
- 1434-9949
- OpenAlex
- W2011335012
- Cited by
- 9
- References
- 15
- Citations by year
- 2020: 1 · 2016: 2 · 2015: 2 · 2013: 2 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- atrial natriuretic peptide, connective tissue diseases, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, plasma ANP levels, proteinuria, serum creatinine, corticosteroid therapy, lung function, cardiac involvement
- MeSH terms
- Adult, Arthritis, Rheumatoid, Creatinine, Electrocardiography, Female, Heart, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Atrial Natriuretic Factor, Osmolar Concentration, Prednisolone, Radiography, Scleroderma, Systemic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
